Dr. Daniel Blumberger is a senior scientist in the VP Research Group and chief, general adult psychiatry & health systems at CAMH. He is the Temerty Chair in Therapeutic Brain Intervention and the director of the Temerty Centre for Therapeutic Brain Intervention at CAMH. He is also a subspecialist in geriatric psychiatry and a professor in the Department of Psychiatry at the University of Toronto.
Areas of Research
Dr. Blumberger’s research focuses on the use of brain stimulation therapies for refractory psychiatric disorders. His main research focuses on clinical intervention trials of novel treatments and understanding the neurophysiology of treatment-resistant depression across the lifespan. His research has been funded by the Canadian Institutes of Health Research, National Institute of Health, Brain Canada, Weston Brain Institute, Brain and Behavior Research Foundation, and Patient- Centered Outcomes Research Institute. He is the principal investigator or co-investigator on multiple clinical trials using different brain stimulation modalities including: magnetic seizure therapy (MST), repetitive transcranial magnetic stimulation (rTMS), deep rTMS and transcranial direct current stimulation (tDCS).
View Dr. Blumberger’s publications on PubMed.